ARTICLE | Company News
Helsinn, Chugai sales and marketing update
September 28, 2015 7:00 AM UTC
Chugai launched Akynzeo netupitant/palonosetron in the U.K. to prevent chemotherapy-induced nausea and vomiting (CINV). The cost of the fixed-dose combination of 300 mg netupitant, a neurokinin 1 (...